Abstract

IntroductionSpinal cord injury (SCI) is a neurological, medically incurable disorder. Human pluripotent stem cells (hPSCs) have the potential to generate neural stem/progenitor cells (NS/PCs), which hold promise in the treatment of SCI by transplantation. In our study, we aimed to establish a chemically defined culture system using serum-free medium and ascorbic acid (AA) to generate and expand long-term self-renewing neuroepithelial-like stem cells (lt-NES cells) differentiated from hPSCs effectively and stably.MethodsWe induced human embryonic stem cells (hESCs)/induced PSCs (iPSCs) to neurospheres using a newly established in vitro induction system. Moreover, lt-NES cells were derived from hESC/iPSC-neurospheres using two induction systems, i.e., conventional N2 medium with gelatin-coated plates (coated) and N2+AA medium without pre-coated plates (AA), and were characterized by reverse transcription polymerase chain reaction (RT-PCR) analysis and immunocytochemistry staining. Subsequently, lt-NES cells were induced to neurons. A microelectrode array (MEA) recording system was used to evaluate the functionality of the neurons differentiated from lt-NES cells. Finally, the mechanism underlying the induction of lt-NES cells by AA was explored through RNA-seq and the use of inhibitors.ResultsHESCs/iPSCs were efficiently induced to neurospheres using a newly established induction system in vitro. lt-NES cells derived from hESC/iPSC-neurospheres using the two induction systems (coated vs. AA) both expressed the neural pluripotency-associated genes PAX6, NESTIN, SOX1, and SOX2. After long-term cultivation, we found that they both exhibited long-term expansion for more than a dozen generations while maintaining neuropluripotency. Moreover, the lt-NES cells retained the ability to differentiate into general functional neurons that express β-tubulin at high levels. We also demonstrated that AA promotes the generation and long-term expansion of lt-NES cells by promoting collagen synthesis via the MEK-ERK1/2 pathway.ConclusionsThis new chemically defined culture system was stable and effective regarding the generation and culture of lt-NES cells induced from hESCs/iPSCs using serum-free medium combined with AA. The lt-NES cells induced under this culture system maintained their long-term expansion and neural pluripotency, with the potential to differentiate into functional neurons.Graphical abstract

Highlights

  • Spinal cord injury (SCI) is a neurological, medically incurable disorder

  • HESCs/induced PSCs (iPSCs) were efficiently induced to neurospheres using a newly established induction system in vitro. lt-NES cells derived from human embryonic stem cells (hESCs)/iPSC-neurospheres using the two induction systems both expressed the neural pluripotency-associated genes PAX6, NESTIN, SOX1, and SOX2

  • This new chemically defined culture system was stable and effective regarding the generation and culture of lt-NES cells induced from hESCs/iPSCs using serum-free medium combined with AA

Read more

Summary

Introduction

Spinal cord injury (SCI) is a neurological, medically incurable disorder. Human pluripotent stem cells (hPSCs) have the potential to generate neural stem/progenitor cells (NS/PCs), which hold promise in the treatment of SCI by transplantation. Spinal cord injury (SCI) is a destructive neurodegenerative disorder with life-long consequences that often leads to irreversible changes because of the loss of neurons and glial cells [1, 2]. Many experimental animal models have been generated to simulate human SCI, and the transplantation of neural stem/progenitor cells (NS/PCs) has been shown to be an effective treatment to cure neurological disorders and repair damaged brain tissue because of their ability to differentiate into neurons and glial cells and their competence to secrete neurotrophic factors [3, 4]. NS/PCs derived from the human fetal brain [6, 7] have been transplanted into injured spinal cord models in mice or nonhuman primates [6, 8], greatly promoting the development of stem-cell-based transplantation therapy for human patients. This fact has been a major hindrance to the clinical use of human NS/PCs [9]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call